Deep Health AI India Ltd (DDIL) — shareholding pattern, promoter holding, financials and share price
About Deep Health AI India Ltd (DDIL)
Deep Health AI India Ltd operates in the Gems, Jewellery And Watches industry, within the Consumer Durables sector. It trades on the NSE as DDIL and on the BSE under scrip code 539559. Its ISIN is INE005G01026.
Incorporated in 1993, Deep Diamond India Ltd is in the business of trading Diamond, Jewellery and Pharma products [1]
Deep Diamond India Limited is primarily engaged in the business of rough and polished diamonds, as well as the sale and trading of diamond-studded and gold jewelry.
The company has diversified its business portfolio by entering the consultancy services sector for the pharmaceutical industry starting from the financial year 2022-23.
Listed peers in Gems, Jewellery And Watches: Homre Ltd, Kanani Industries Ltd, Manoj Jewellers Ltd, Kenvi Jewels Ltd, Goenka Diamond & Jewels Ltd, Shubhlaxmi Jewel Art Ltd.
Valuation & Returns
10 Jul 2026At ₹2.07 a share on 10 Jul 2026, Deep Health AI India Ltd (DDIL) was valued at a price-to-earnings ratio of 26.64x against an industry P/E of 50.62x and a price-to-book of 1.46x on a book value of ₹1.42 per share as of Mar 2024. Solomo computes return on equity of 5.49% and return on capital employed of 7.43% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 26.64x
- Industry P/E
- 50.62x
- P/B
- 1.46x
- EPS (TTM)
- ₹0.08
- Book value / share
- ₹1.42
- ROE
- 5.49%
- ROCE
- 7.43%
- ROA
- 4.86%
- Debt / equity
- 0.08x
- Dividend yield
- 4.83%
- EBITDA margin
- 38.59%
- 52-week range
- ₹1.65 – ₹10.29
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Deep Health AI India Ltd (DDIL) reported revenue of ₹4.25 crore, net profit of ₹1.13 crore and earnings per share of ₹0.08. That compares with revenue of ₹1.25 crore and net profit of ₹0.88 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹0.25 crore and net profit ₹-4.51 crore (consolidated).
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue (₹ cr) | 7.67 | 2.56 | 1.25 | 4.25 |
| Net profit (₹ cr) | 1.26 | 0.42 | 0.88 | 1.13 |
| EPS (₹) | 0.13 | 0.04 | 0.09 | 0.08 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 0.79% | 9.21% | -3.30% | -50.78% |
| Profit growth | - | - | 63.46% | 109.52% |
| Stock price CAGR | 5% | 13% | -31% | -51% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 0.03% of Deep Health AI India Ltd (DDIL) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.35%. Market capitalisation was ₹30 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2015.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 0.03% | - | 0.35% | - | 99.97% |
| Mar 2026 | 0.03% | - | 0.35% | 0% | 99.97% |
| Dec 2025 | 0.03% | - | 0.35% | 0% | 99.97% |
| Sep 2025 | 0.03% | - | 0.35% | - | 99.97% |
| Jun 2025 | 0.08% | - | 1.04% | - | 99.92% |
| Mar 2025 | 0.08% | - | 1.04% | - | 99.92% |
| Dec 2024 | 0.08% | - | 1.04% | - | 99.92% |
| Sep 2024 | 0.08% | - | 1.04% | - | 99.92% |